Roll Call: TN HB1059 | 2017-2018 | 110th General Assembly
For additional roll call votes on Tennessee HB1059 please see the Vote List
Bill Title: As introduced, prohibits an insurance policy that provides benefits for anti-cancer medications that are injected or intravenously administered by a healthcare provider and anti-cancer medications that are patient administered from requiring a higher copayment, deductible, or coinsurance amount for the patient administered anti-cancer medication than for the injected or intravenously administered anti-cancer medication. - Amends TCA Title 56, Chapter 7, Part 23.
Spectrum: Slight Partisan Bill (Republican 26-9)
Status: (Introduced - Dead) 2017-04-04 - Sponsor(s) Added. [HB1059 Detail]
Text: Latest bill text (Draft #1) [PDF]
Bill Title: As introduced, prohibits an insurance policy that provides benefits for anti-cancer medications that are injected or intravenously administered by a healthcare provider and anti-cancer medications that are patient administered from requiring a higher copayment, deductible, or coinsurance amount for the patient administered anti-cancer medication than for the injected or intravenously administered anti-cancer medication. - Amends TCA Title 56, Chapter 7, Part 23.
Spectrum: Slight Partisan Bill (Republican 26-9)
Status: (Introduced - Dead) 2017-04-04 - Sponsor(s) Added. [HB1059 Detail]
Text: Latest bill text (Draft #1) [PDF]
Vote: INSURANCE AND BANKING COMMITTEE: Rec. for pass. if am., ref. to Calendar & Rules Committee
| Vote | Tally | Democrat | Republican |
|---|---|---|---|
| Yea | 16 | 4 | 12 |
| Nay | 2 | 1 | 1 |
| Not Voting | - | - | - |
| Absent | - | - | - |
| TOTAL | 18 | 5 | 13 |
